Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Condition: Parkinson Disease · Sponsor: Gateway Institute for Brain Research
About this study
This study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.
This description comes directly from the study's public registry record.
Talk to the study team
Susana Restrepo, PhD · 786-216-5334 · srestrepo@gifbr.com
Vanesa Javier · 954-636-2166 · vaday@gifbr.com
Always discuss trial participation with your own doctor first.
Locations (4)
| Institute for Neuroimmune Medicine | Davie, Florida, United States | Recruiting |
| Las Mercedes Medical Research | Hialeah, Florida, United States | Recruiting |
| NextGen Research Group | Miami, Florida, United States | Recruiting |
| Charter Research | The Villages, Florida, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05266417